The Obama administration intends to require drugmakers to give rebates to some 10 million people who qualify for both Medicare and Medicaid and subscribe to the Medicare Part D program. The move could reduce spending by $137 billion, according to Congressional Budget Office estimates, but the drug industry says it would cut money available for research and development.

Full Story:

Related Summaries